Daprodustat.

The article offers information on daprodustat, a hypoxia-inducible factor prolyl hydroxylase (HIF PH) inhibitor and a hematopoietic agent. Its uses include for the treatment of anemia due to chronic kidney disease in adults who have been receiving dialysis for at least four months. Also mentioned are its dosage and administration, drug interactions, and advice to patients.